Quarterly report pursuant to Section 13 or 15(d)


6 Months Ended
Jul. 03, 2021
Receivables [Abstract]  
Allowance for Doubtful Accounts
The Company reviews the estimates used to calculate the allowance for doubtful accounts on a quarterly basis.

The following table presents a rollforward of the allowance for doubtful accounts:
Six Months Ended June
(In thousands) 2021 2020
Balance, December $ 19,143  $ 11,852 
Provision for expected credit losses 783  18,012 
Accounts receivable balances written off (1)
(4,119) (7,502)
Other (2)
(325) (713)
Balance, June $ 15,482  $ 21,649 
(1) Accounts receivable balances written off against the allowance were primarily due to the bankruptcy of a major U.S. retail customer during the second quarter of 2020, write-offs related to our India business during 2021 as well as the impact of COVID-19 during the 2021 and 2020 periods.
(2) Other primarily includes the impact of foreign currency translation and recoveries of amounts previously written off, none of which were individually significant.
Sale of Trade Accounts Receivable
On April 1, 2019, the Company entered into an agreement with a financial institution to sell selected trade accounts receivable on a nonrecourse basis. Under this agreement, up to $377.5 million of the Company’s trade accounts receivable may be sold to the financial institution and remain outstanding at any point in time. The Company removes the sold balances from "accounts receivable, net" in its balance sheet at the time of sale. The Company does not retain any interests in the sold trade accounts receivable but continues to service and collect outstanding trade accounts receivable on behalf of the financial institution.
During the six months ended June 2021 and June 2020, the Company sold total trade accounts receivable of $586.8 million and $405.8 million, respectively. As of June 2021, December 2020 and June 2020, $183.0 million, $127.1 million and $144.5 million, respectively, of the sold trade accounts receivable had been removed from the Company's balance sheets but remained outstanding with the financial institution.
The funding fees charged by the financial institution for this program are reflected in the Company's statements of operations within "other expense, net" and were $0.3 million and $0.9 million for the three and six months ended June 2021, respectively, and $0.3 million and $1.1 million for the three and six months ended June 2020, respectively. Net proceeds of this program are reflected as operating activities in the Company's statements of cash flows.